Yasuo Oshiro

Novel Antipsychotic Agents with Dopamine Autoreceptor Agonist Properties:  Synthesis and Pharmacology of 7-[4-(4-Phenyl-1-piperazinyl)butoxy]-3,4-dihydro-2(1<i>H</i>)-quinolinone Derivatives

Yasuo Oshiro, Seiji Sato, Nobuyuki Kurahashi et al. · Journal of Medicinal Chemistry · 1998 · 142 citations

Medicine, Medicinal Chemistry, Pharmacology +17

3,4-Dihydro-2(1<i>H</i>)-quinolinone as a Novel Antidepressant Drug:  Synthesis and Pharmacology of 1-[3-[4-(3-Chlorophenyl)-1-piperazinyl]propyl]-3,4- dihydro-5-methoxy-2(1<i>H</i>)-quinolinone and Its Derivatives

Yasuo Oshiro, Yoji Sakurai, Seiji Sato et al. · Journal of Medicinal Chemistry · 2000 · 93 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16

Studies on 2(1H)-quinolinone derivatives as neuroleptic agents. I. Synthesis and biological activities of (4-phenyl-1-piperazinyl)-propoxy-2(1H)-quinolinone derivatives.

Kazuo Banno, Takafumi Fujioka, Tetsuro Kikuchi et al. · Chemical and Pharmaceutical Bulletin · 1988 · 38 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +13

Soft Drugs VI. The Application of the Inactive Metabolite Approach for Design of Soft β-Blockers1?2

Nicholas Bodor, Yasuo Oshiro, Michael J. Katovich et al. · Pharmaceutical Research · 1984 · 25 citations

Pharmacy, Medicinal Chemistry, Pharmacology +15

Attenuation of Scopolamine-Induced and Age-Associated Memory Impairments by the Sigma and 5-Hydroxytryptamine1A Receptor Agonist OPC-14523 (1-{3-[4-(3-chlorophenyl)-1-piperazinyl]propyl}-5-methoxy-3,4-dihydro-2[1 H]-quinolinone monomethanesulfonate)

Katsura Tottori, Masami Nakai, Yasufumi Uwahodo et al. · Journal of Pharmacology and Experimental Therapeutics · 2002 · 24 citations

Life Sciences, Neuroscience, Pharmacology +17